WHO Recommends Against GLP-1s For Young Kids—Amid Wegovy Trial For 6 Year Olds

Fecha de publicación: 7 de octubre de 2026, 15:06

Despite a nearly 600% surge in adolescent GLP-1 prescriptions, the WHO says they may pose critical safety risks to growing bodies.